38
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Patterns, Risk Factors, and Outcomes of Recurrence After Hepatectomy for Hepatocellular Carcinoma with and without Microvascular Invasion

, ORCID Icon, , ORCID Icon, ORCID Icon &
Pages 801-812 | Received 06 Sep 2023, Accepted 24 Apr 2024, Published online: 07 May 2024

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca a Cancer J Clinicians. 2021;71:209–249. doi:10.3322/caac.21660
  • Fan ST, Mau Lo C, Poon RT, et al. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg. 2011;253:745–758. doi:10.1097/SLA.0b013e3182111195
  • Goh BKP, Chua DW, Koh YX, et al. Continuous improvements in short and long-term outcomes after partial hepatectomy for hepatocellular carcinoma in the 21st century: Single institution experience with 1300 resections over 18 years. Surg Oncol. 2021;38:101609. doi:10.1016/j.suronc.2021.101609
  • Pompili M, Saviano A, de Matthaeis N, et al. Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey. J Hepatol. 2013;59:89–97. doi:10.1016/j.jhep.2013.03.009
  • Roayaie S, Obeidat K, Sposito C, et al. Resection of hepatocellular cancer ≤2 cm: results from two Western centers. Hepatology. 2013;57:1426–1435. doi:10.1002/hep.25832
  • Hwang S, Lee YJ, Kim KH, et al. The impact of tumor size on long-term survival outcomes after resection of solitary hepatocellular carcinoma: single-institution experience with 2558 patients. J Gastrointestinal Surg. 2015;19:1281–1290. doi:10.1007/s11605-015-2849-5
  • Roayaie S, Blume IN, Thung SN, et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology. 2009;137:850–855. doi:10.1053/j.gastro.2009.06.003
  • Rodríguez-Perálvarez M, Luong TV, Andreana L, Meyer T, Dhillon AP, Burroughs AK. A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. Ann Surg Oncol. 2013;20:325–339. doi:10.1245/s10434-012-2513-1
  • Shindoh J, Kobayashi Y, Kawamura Y, et al. Microvascular invasion and a size cutoff value of 2 cm predict long-term oncological outcome in multiple hepatocellular carcinoma: reappraisal of the American Joint Committee on Cancer staging system and validation using the surveillance, epidemiology, and end-results database. Liver Can. 2020;9:156–166. doi:10.1159/000504193
  • Zhang XP, Wang K, Wei XB, et al. An Eastern hepatobiliary surgery hospital microvascular invasion scoring system in predicting prognosis of patients with hepatocellular carcinoma and microvascular invasion after r0 liver resection: a large-scale, multicenter study. oncologist. 2019;24:e1476–e88. doi:10.1634/theoncologist.2018-0868
  • Lee S, Kang TW, Song KD, et al. Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation. Ann Surg. 2021;273:564–571. doi:10.1097/SLA.0000000000003268
  • Nitta H, Allard MA, Sebagh M, et al. Prognostic value and prediction of extratumoral microvascular invasion for hepatocellular carcinoma. Ann Surg Oncol. 2019;26:2568–2576. doi:10.1245/s10434-019-07365-0
  • Jung SM, Kim JM, Choi GS, et al. Characteristics of early recurrence after curative liver resection for solitary hepatocellular carcinoma. J Gastrointestinal Surg. 2019;23:304–311. doi:10.1007/s11605-018-3927-2
  • Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-The ALBI grade. J Clinical Oncology. 2015;33:550–558. doi:10.1200/JCO.2014.57.9151
  • Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954;7:462–503. doi:10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E
  • Li SQ, Huang T, Shen SL, et al. Anatomical versus non-anatomical liver resection for hepatocellular carcinoma exceeding Milan criteria. Br J Surg. 2017;104:118–127. doi:10.1002/bjs.10311
  • Shi M, Guo RP, Lin XJ, et al. Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg. 2007;245:36–43. doi:10.1097/01.sla.0000231758.07868.71
  • Poon RT, Fan ST, Ng IO, Wong J. Significance of resection margin in hepatectomy for hepatocellular carcinoma: a critical reappraisal. Ann Surg. 2000;231:544–551. doi:10.1097/00000658-200004000-00014
  • Shimada K, Sakamoto Y, Esaki M, Kosuge T. Role of the width of the surgical margin in a hepatectomy for small hepatocellular carcinomas eligible for percutaneous local ablative therapy. American Journal of Surgery. 2008;195:775–781. doi:10.1016/j.amjsurg.2007.06.033
  • Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dise. 2010;30:61–74. doi:10.1055/s-0030-1247133
  • Portolani N, Coniglio A, Ghidoni S, et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg. 2006;243:229–235. doi:10.1097/01.sla.0000197706.21803.a1
  • Sherman M. Recurrence of hepatocellular carcinoma. New Engl J Med. 2008;359:2045–2047. doi:10.1056/NEJMe0807581
  • Lee KF, Chong CCN, Fong AKW, et al. Pattern of disease recurrence and its implications for postoperative surveillance after curative hepatectomy for hepatocellular carcinoma: experience from a single center. Hepatobiliary Surg Nutr. 2018;7:320–330. doi:10.21037/hbsn.2018.03.17
  • Shah SA, Greig PD, Gallinger S, et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J American Coll Surg. 2006;202:275–283. doi:10.1016/j.jamcollsurg.2005.10.005
  • Imamura H, Matsuyama Y, Tanaka E, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38:200–207. doi:10.1016/S0168-8278(02)00360-4
  • European Association For The Study Of The Liver and other. EASL clinical practice guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018;69:182–236. doi:10.1016/j.jhep.2018.03.019
  • Cha C, Fong Y, Jarnagin WR, Blumgart LH, DeMatteo RP. Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J American Coll Surg. 2003;197:753–758. doi:10.1016/j.jamcollsurg.2003.07.003
  • Kim H, Rhim H, Choi D, et al. Recurrence and treatment pattern in long-term survivors with hepatocellular carcinoma: a comparison between radiofrequency ablation and surgery as a first-line treatment. World j Surg. 2010;34:1881–1886. doi:10.1007/s00268-010-0533-1
  • Yoh T, Seo S, Taura K, et al. Surgery for recurrent hepatocellular carcinoma: Achieving long-term survival. Ann Surg. 2021;273:792–799. doi:10.1097/SLA.0000000000003358
  • Xu XF, Xing H, Han J, et al. Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China. JAMA Surgery. 2019;154:209–217. doi:10.1001/jamasurg.2018.4334
  • Lee HA, Lee YS, Kim BK, et al. Change in the recurrence pattern and predictors over time after complete cure of hepatocellular carcinoma. Gut Liver. 2021;15:420–429. doi:10.5009/gnl20101
  • Agopian VG, Harlander-Locke MP, Markovic D, et al. Evaluation of patients with hepatocellular carcinomas that do not produce α-Fetoprotein. JAMA Surgery. 2017;152:55–64. doi:10.1001/jamasurg.2016.3310
  • Duvoux C, Roudot-Thoraval F, Decaens T, et al. Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. Gastroenterology. 2012;143:986–94.e3; quiz e14–5. doi:10.1053/j.gastro.2012.05.052
  • Ben-Porath I, Thomson MW, Carey VJ, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nature Genet. 2008;40:499–507. doi:10.1038/ng.127
  • Attaran S, Bissell MJ. The role of tumor microenvironment and exosomes in dormancy and relapse. Semi Cancer Biol. 2022;78:35–44. doi:10.1016/j.semcancer.2021.09.008
  • Li J, Liu Y, Yan Z, et al. A nomogram predicting pulmonary metastasis of hepatocellular carcinoma following partial hepatectomy. Br. J. Cancer. 2014;110:1110–1117. doi:10.1038/bjc.2014.19
  • Ochiai T, Ikoma H, Okamoto K, Kokuba Y, Sonoyama T, Otsuji E. Clinicopathologic features and risk factors for extrahepatic recurrences of hepatocellular carcinoma after curative resection. World j Surg. 2012;36:136–143. doi:10.1007/s00268-011-1317-y
  • Nakashima Y, Nakashima O, Tanaka M, Okuda K, Nakashima M, Kojiro M. Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatology res. 2003;26:142–147. doi:10.1016/S1386-6346(03)00007-X
  • Shi M, Zhang CQ, Zhang YQ, Liang XM, Li JQ. Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin. World j Surg. 2004;28:376–381. doi:10.1007/s00268-003-7308-x
  • Sasaki A, Kai S, Iwashita Y, Hirano S, Ohta M, Kitano S. Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma. Cancer. 2005;103:299–306. doi:10.1002/cncr.20798
  • Fujita N, Aishima S, Iguchi T, et al. Histologic classification of microscopic portal venous invasion to predict prognosis in hepatocellular carcinoma. Human Pathol. 2011;42:1531–1538. doi:10.1016/j.humpath.2010.12.016